Funding · Company
SonoThera, Inc.
South San Francisco, CABiotech & Pharma
SonoThera, Inc. of South San Francisco, CA has disclosed $156M across 2 Form D offerings filed with the SEC between Dec 29, 2022 and Jun 30, 2026.
$156M
Total disclosed
2
Form D offerings
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$30M
Form D · Dec 29, 2022 ↗
Q4 2022
· target $61M
Filing details
HeadquartersSouth San Francisco, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001945154Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →